{"symbol": "MRKR", "companyName": "Marker Therapeutics Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.markertherapeutics.com", "description": "TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.", "CEO": "Peter L. Hoang", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}